Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.26137 | 10 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.25888 | 10 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.25014 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.19081 | 10 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.20579 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.31865 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.51681 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.23955 | 10 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.23655 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.25473 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.25406 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.23421 | 10 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.25043 | 10 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.25734 | 11 |